A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice.

求助中 10 由 Starmer 发布于 2026/3/12 10:38:17

DOI:10.1038/s41564-026-02279-6
作者：Haiyan Zhou,Ruiming Sun,Xiaoqun Nie,Liliang Xia,Hui Dong,Yujie Liu,Shurui Hou,Wenyue Dong,Xiaokuan Zhu,Yaxian Yao,Guo-Ping Zhao,Shun Lu,Ying Wang,Chen Yang
文献类型：期刊论文
补充材料：只需要正文

Nature

Abstract：Targeting the gut microbiota is a promising strategy to enhance the efficiency of cancer immunotherapy; however, success has been limited. Here we combined metagenomic analysis and in silico

应助信息

等您来应助

上传文件

10小时前

青丹木筝

e1b7c7441dbd11f19d5734735aa3bc31.pdf 已驳回

10小时前

Book学术机器人

2026/3/12 10:38:17 未找到该文献，机器人已退出，请等待人工下载

2026/3/12 10:38:17 Book学术AI机器人收到请求，开始寻找文献

2026/3/12 10:38:17 已向机器人发送请求

10小时前

Starmer 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SageNovel Method to Target Apical Periodontitis Worsened by Inflammatory Bowel Disease